哥伦比亚麦德林及都会区2016-2017年孕妇百日咳免疫接种的效果
在哥伦比亚麦德林及安蒂奥基亚都会区8家随机选择的医院开展队列研究,评估孕妇接种Tdap对母体/脐带抗体浓度及婴儿出生后6个月内百日咳发生的影响。共检测805名接种孕妇和200名接种前孕妇的配对血清,随访896名婴儿,确认2例百日咳(发病率1.99/1000)。结论认为观察到Tdap孕妇接种对百日咳的预期效果。
要点
- 接种孕妇抗体浓度高于未接种孕妇,接种前后抗体水平差异有统计学意义(Wilcoxon检验P=0.000)。
- 脐带与母体抗体呈正相关,母体/脐带抗体滴度>100 IU/mL的 prevalence 分别为18.40%和23.1%。
- 婴儿中确认2例百日咳,发病率为1.99/1000。
核心结论
- 观察到Tdap孕妇接种对百日咳的预期效果。
研究设计与样本
- 2015-2016年在哥伦比亚麦德林及安蒂奥基亚都会区8家随机选择的医院开展队列研究。
- 从805名分娩时招募的已接种孕妇和200名产前保健时(接种前)招募并随访至分娩的孕妇中测量配对母体与脐带血清IgG PT抗体水平。
- 随访896名婴儿以检测急性呼吸道感染及咳嗽阵发、吸气性吼声、呼吸暂停、发绀或咳后呕吐。
主要发现
- 抗体滴度>100 IU/mL的 prevalence:母体18.40%(95%CI 16-21%),脐带23.1%(95%CI 19.2-27.4%)。
- 脐带与母体抗体呈正相关,接种孕妇抗体浓度高于未接种孕妇,接种前后抗体水平差异有统计学意义(Wilcoxon检验P=0.000)。
- 若孕妇在妊娠26至30周接种且接种距分娩最多8周,经胎盘转运率更高。
- 婴儿中确认2例百日咳,发病率为1.99/1000。
关键数值与推荐
- 采用商业ELISA试剂盒分析抗体。
- 采用百日咳鲍特菌特异性实时PCR进行实验室确认。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2013, pertussis immunization (Tdap) for pregnant women was implemented in Colombia to protect newborns in response to increased pertussis incidence. OBJECTIVE: To assess the effect of Tdap maternal immunization on the concentration of mother/umbilical cord antibodies and the occurrence of pertussis in infants during their first six months of life. METHODS: A cohort study in eight randomly selected hospitals in Medellin and metropolitan area of Antioquia, Colombia was conducted in 2015-2016. IgG PT antibody levels in paired maternal and umbilical cord sera were measured from 805 mothers immunized recruited during labor and 200 mothers recruited during the prenatal care before immunization and followed until delivery. Antibodies were analyzed by commercial ELISA kits. 896 infants were followed to detect acute respiratory infections and paroxysms of coughing, inspiratory whoop, apnea, cyanosis or post-tussive vomiting. For laboratory confirmation, B. pertussis- specific real time PCR was performed. RESULTS: We observed a high prevalence of titers >100 IU/mL (mother: 18.40% [95% CI 16-21%]; umbilical cord: 23.1% [95% CI 19.2-27.4%]), positive correlation of umbilical cord and maternal antibodies, higher antibody concentration in vaccinated than in non-vaccinated mothers and significant difference in antibody levels before and after vaccination (Wilcoxon test p = 0.000). The trans placental transport ratio was higher if the mother was vaccinated between 26 and 30 weeks of pregnancy and maximum eight weeks before delivery. Two cases of pertussis were confirmed in infants (incidence of 1.99 per 1000). CONCLUSION: The expected effect of Tdap maternal vaccination against pertussis was observed.
引用
- Hincapié-Palacio D, Hoyos MC, Ochoa J, et al. Effect of maternal immunization against pertussis in Medellin and the metropolitan area, Colombia, 2016-2017. Vaccine. 2018. PMID: 29789240. doi:10.1016/j.vaccine.2018.05.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。